S322-0325 Screening compound: 2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(2,5-dimethoxyphenyl)-4H-1,2,4-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide

S322-0325 Screening compound: 2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(2,5-dimethoxyphenyl)-4H-1,2,4-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide
S322-0325 Screening compound: 2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(2,5-dimethoxyphenyl)-4H-1,2,4-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S322-0325
2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(2,5-dimethoxyphenyl)-4H-1,2,4-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S322-0325

Molecular Formula

C32H33N5O5S2 (C32 H33 N5 O5 S2)

Compound Name

2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(2,5-dimethoxyphenyl)-4H-1,2,4-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide

IUPAC name

2-({5-[1-(benzenesulfonyl)-1H-indol-3-yl]-4-(25-dimethoxyphenyl)-4H-124-triazol-3-yl}sulfanyl)-N-cyclohexylacetamide

SMILES

COc(cc1)cc(-n2c(SCC(NC3CCCCC3)=O)nnc2-c(c2c3cccc2)cn3S(c2ccccc2)(=O)=O)c1OC

InChI

InChI=1S/C32H33N5O5S2/c1-41-23-17-18-29(42-2)28(19-23)37-31(34-35-32(37)43-21-30(38)33-22-11-5-3-6-12-22)26-20-36(27-16-10-9-15-25(26)27)44(39,40)24-13-7-4-8-14-24/h4,7-10,13-20,22H,3,5-6,11-12,21H2,1-2H3,(H,33,38)

InChI Key

SJZIYJUOXMWNGP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27618209

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

631.78

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

5.609

Distribution Coefficient, logD

5.609

Water Solubility, LogSw

-5.49

Polar Surface Area

92.775

Acid Dissociation Constant (pKa)

15.85

Base Dissociation Constant (pKb)

1.85

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.10

S322-0325 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with S322-0325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S322-0325?
Check Price and Availability of S322-0325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S322-0325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S322-0325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S322-0325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S322-0325 available by request